Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progression.
Saved in:
| Title: | Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progression. |
|---|---|
| Authors: | Grobben M; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam, The Netherlands.; Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, The Netherlands., Bakker M; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam, The Netherlands.; Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, The Netherlands., Schriek AI; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam, The Netherlands.; Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, The Netherlands., Levels LJJ; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam, The Netherlands.; Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, The Netherlands., Umotoy JC; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam, The Netherlands.; Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, The Netherlands., Tejjani K; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam, The Netherlands.; Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, The Netherlands., van Breemen MJ; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam, The Netherlands.; Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, The Netherlands., Lin RN; The Scripps Research Institute, Department of Structural Biology and Computational Biology, La Jolla, California, United States of America., de Taeye SW; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam, The Netherlands.; Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, The Netherlands., Ozorowski G; The Scripps Research Institute, Department of Structural Biology and Computational Biology, La Jolla, California, United States of America., Kootstra NA; Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, The Netherlands.; Amsterdam UMC, location University of Amsterdam, Department of Experimental Immunology, Amsterdam, The Netherlands., Ward AB; The Scripps Research Institute, Department of Structural Biology and Computational Biology, La Jolla, California, United States of America., Kent SJ; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Department of Microbiology and Immunology, Melbourne, Australia.; Alfred Hospital and Central Clinical School, Monash University, Melbourne Sexual Health Centre and Department of Infectious Diseases, Melbourne, Australia., Hogarth PM; Burnet Institute, Immune Therapies Group, Melbourne, Australia.; Central Clinical School, Monash University, Department of Immunology, Melbourne, Australia., Wines BD; Burnet Institute, Immune Therapies Group, Melbourne, Australia.; Central Clinical School, Monash University, Department of Immunology, Melbourne, Australia., Sanders RW; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam, The Netherlands.; Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, The Netherlands.; Weill Medical College of Cornell University, Department of Microbiology and Immunology, New York, New York, United States of America., Chung AW; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Department of Microbiology and Immunology, Melbourne, Australia., van Gils MJ; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam, The Netherlands.; Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, The Netherlands. |
| Source: | PLoS pathogens [PLoS Pathog] 2024 Dec 11; Vol. 20 (12), pp. e1012739. Date of Electronic Publication: 2024 Dec 11 (Print Publication: 2024). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1553-7374 |
|---|---|
| DOI: | 10.1371/journal.ppat.1012739 |
